Design a Western Blot for SARS2

Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.

Isoforms · UniProt lists isoforms 1 and 2. In isoform 2, the sequence at canonical positions 132–155 is replaced. This could affect migration or antibody recognition, but the features do not establish a distinct visible band. Check whether the antibody recognizes the replaced region before assigning bands to isoforms.

PTM · UniProt lists N6-acetyllysine at position 110 and N6-succinyllysine at position 195, using its supplied sequence coordinates. Neither feature alone demonstrates a visible shift. Keep these coordinates explicit when comparing results that use different residue numbering.

Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.

Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.

Blocking · Standard workflow guidance: follow the A08425-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.

Quantitation · Use a consistent band definition across samples and report whether quantitation targets the observed ~53 kDa band or includes additional bands. The listed isoforms and modifications do not establish which bands represent SARS2, so verify any additional band before adding it to the measurement.

Interpretation · The supplied apparent band is ~53 kDa, versus a predicted mass of 58.3 kDa. SARS2 is listed with a transit peptide keyword and mitochondrial matrix localization, but no cleavage coordinate is supplied. These features do not establish the cause of the difference; confirm the band with an independent SARS2-specific check.

SARS2 has a transit peptide keyword and is assigned to the mitochondrial matrix. The supplied features give no transit-peptide boundary or cleavage site. Consider processing when investigating migration, but do not calculate a mature-protein mass or assign the ~53 kDa band from these features alone.

SARS2 is annotated as a homodimer. That describes its protein association, but does not establish that a dimer survives Western-blot preparation or appears as a higher band. Verify the band before assigning it to a dimer.

Compare it with the observed ~53 kDa band and the 58.3 kDa predicted mass. The isoform 2 sequence replacement and transit peptide annotation provide possibilities to investigate, but neither identifies an unexpected band. Check antibody specificity and the band’s reproducibility before assigning an identity.